Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
KAITLYN ARSENAULT Insider Profile
4 Followers
KAITLYN ARSENAULT, CFO at Skye Bioscience, holds 166.34K shares in Skye Bioscience (Ticker: SKYE). Most recently, KAITLYN ARSENAULT Sold $43,396 shares of Skye Bioscience on Nov 19, 2024 for an estimated value of 216.65K.
KAITLYN ARSENAULT has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of KAITLYN ARSENAULT's holdings
Insider Roles
CFO
Roles that KAITLYN ARSENAULT holds in companies
Most Profitable Insider Trade
The most profitable trade made by KAITLYN ARSENAULT
KAITLYN ARSENAULT's Trading History
List of latest transactions for each holding click on a transaction to see KAITLYN ARSENAULT's performance on stock
You May Also Like
KAITLYN ARSENAULT insider profile FAQ
What is the percentage of profitable transactions made by KAITLYN ARSENAULT?
The percentage of profitable transactions made by KAITLYN ARSENAULT is ―.
What is the average return per transaction made by KAITLYN ARSENAULT?
The average return per transaction made by KAITLYN ARSENAULT is ―.
What stocks does KAITLYN ARSENAULT hold?
KAITLYN ARSENAULT holds: SKYE stocks.
What was KAITLYN ARSENAULT’s latest transaction?
KAITLYN ARSENAULT latest transaction was an Informative Sell of $216.65K.
What was KAITLYN ARSENAULT's most profitable transaction?
KAITLYN ARSENAULT’s most profitable transaction was an Informative Sell of SKYE stock on November 19, 2024. The return on the trade was 37.70%.
What is KAITLYN ARSENAULT's role in Skye Bioscience?
KAITLYN ARSENAULT's role in Skye Bioscience is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.